Journal
JOURNAL OF IMMUNOLOGY
Volume 183, Issue 5, Pages 3268-3277Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0900894
Keywords
-
Categories
Funding
- NIH [AI049361]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049361, R56AI049361] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Nur77, an orphan nuclear receptor, plays a key role in apoptosis in T cells. In cancer cell lines, Nur77 can induce apoptosis through the intrinsic apoptotic pathway, but the mechanism by which Nur77 kills T cells remains controversial. In this study, we provide biochemical, pharmacological, and genetic evidence demonstrating that Nur77 induces apoptosis through the activation of the intrinsic pathway in T cells. We also show that Nur77 is a physiological substrate of the MEK-ERK-RSK cascade. Specifically, we demonstrate that RSK phosphorylates Nur77 at serine 354 and this modulates Nur77 nuclear export and intracellular translocation during T cell death. Our data reveal that Nur77 phosphorylation and mitochondrial targeting, regulated by RSK, defines a role for the MEK1/2-ERK1/2 cascade in T cell apoptosis. The Journal of Immunology, 2009, 183: 3268-3277.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available